Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0370
+0.0010 (2.78%)
At close: Jan 9, 2026
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 29.98 million as of January 9, 2026. Its market cap has increased by 146.82% in one year.
Market Cap
29.98M
Enterprise Value
26.94M
Revenue
3.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 29.98M, a decrease of -86.30%. That is a compound annual growth rate of -29.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 29.98M | 2.78% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 81.96B |
| Pro Medicus | 22.46B |
| Cochlear | 17.17B |
| Sonic Healthcare | 10.94B |
| Ramsay Health Care | 8.20B |
| Ansell | 5.07B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |